Clinical Read2026-06-30
CHS-114 (SRF114)
Coherus BioSciences Inc.CHRS
- Indication
- Head and neck squamous cell carcinoma (HNSCC), gastric cancer
- Stage
- Phase 1
- Event
- Phase 1 Data readout
- Details
4/28/25- Presented poster of interim data at AACR'25. 2L Ph1 dose optimization study ongoing. 11/06/25:- Biomarker data presented at SITC'25; CRC cohort added; data in H1, Mid, H2 2026. 03/09/26:- PR No update. 05/11/26:- PR No update.
Financial Snapshot
Market Cap
$209.8M
Price
$1.39